Study on effects of a plant-derived protein containing food product on postprandial hyperglycemia
- Conditions
- Postprandial hyperglycemia
- Registration Number
- JPRN-UMIN000014533
- Lead Sponsor
- Kao Corporation
- Brief Summary
There was a significantly difference in the primary outcome between the groups
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Not provided
1, Person who is difficult to participate the study due to dysfunctions of liver, kidney, heart, respiration, endocrine secretion, metabolism, nervous system, consciousness or diabetes, or the other dysfunctions 2, Person who was given surgery for a disease or an injury 2 months prior to the study 3, Person who was given gastrectomy and/or bypass of part of the intestine 4, Person who takes medication for glucose or fat metabolism, or hypertension 5, Person who habitually consumes the foods for specific health use (FOSHU) and/or dietary supplements (capsules) (except for person who can stop to consume them right after informed consent) 6, Person who is or had been given treatment for allergies to test food ingredients 7, Person who has been ill due to blood collecting 8, Person who donated 200mL or more of blood within a month prior to the study 9, Person who skip breakfast habitually 10, Heavy smoker or person who cannot stop
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method postprandial blood glucose
- Secondary Outcome Measures
Name Time Method Insulin, TG, GIP, GLP-1, ghrelin, appetite (satiety)